ARA-290 (Cibinetide) is an experimental peptide derived from erythropoietin (EPO) studied in the laboratory for its role in cell protection mechanisms, inflammatory modulation and tissue repair.
Primarily used in research to explore nerve regeneration and cellular recovery processes after physiological stress.
Composition
ARA-290 — 10 mg per vial (lyophilized form)
Experimental exhibition
• Quantities studied: 0.5–2 mg in preclinical research
• Exploration of cellular protection pathways
• Analysis of inflammatory responses
• Studies conducted in controlled environments
Informative benefits
• Studied for the protection of cellular tissues
• Research on nerve recovery
• Observation of inflammatory modulation
• Exploration of local regeneration
• Analysis of cellular repair mechanisms
For research use only – Not intended for human consumption.
